Israel Corp Beyond ICL: Do Prodalim, AKVA and NOAP Already Form a Real Second Value Layer
Israel Corp’s non-ICL holdings already add up to a visible value layer of about $244 million, but nearly two thirds of it sits in Prodalim. This is no longer a marginal option, though it is still not a real second earnings engine.
What This Follow-Up Is Testing
The main article already established that diversification outside ICL exists, but it is still small. This follow-up isolates a narrower question: do Prodalim, AKVA and NOAP already give Israel Corp a real second layer of value, or are they still mostly a basket of attractive options.
The short answer is yes, but only partly. There is already a real second value layer because the numbers are no longer trivial and they are now observable in market terms. Shortly before the annual report was published, the combined value of the holdings in Prodalim, AKVA and NOAP stood at about $244 million. That is no longer a side note inside a holding company still dominated by one flagship asset. The problem is that this layer still does not look like a second engine. It is highly concentrated in Prodalim, AKVA has only roughly come back to entry-level economics, and NOAP still sits at a stage where the operating promise is larger than the current economic weight.
In other words, this is now a value layer, not yet a second earnings layer. Anyone looking for proof that Israel Corp has already built a second floor capable of materially balancing its dependence on ICL still does not get that proof from this filing. Anyone looking for evidence that diversification has moved from a conceptual strategy into something measurable does.
The First Number That Matters
Shortly before publication, the three holdings were worth about $244 million combined: Prodalim at roughly $155 million, AKVA at roughly $73 million and NOAP at roughly $16 million. Nearly two thirds of that layer sits in Prodalim, AKVA accounts for about a third, and NOAP remains comparatively small.
That number matters for two reasons. First, it shows that diversification is no longer symbolic. Second, it exposes a new concentration inside the diversification itself. An investor telling himself that Israel Corp already has a diversified portfolio outside ICL is missing the fact that the new basket still leans heavily on one holding.
The same picture appears when looking at disclosed investment basis. AKVA was acquired for about $74 million, NOAP was built through three funding rounds totaling about $13.3 million, and Prodalim was acquired through a total investment of about $116 million. Against that combined disclosed basis of about $203.3 million, the filing now points to a combined market value of about $244 million. That means about $40.7 million of value creation using the company’s own disclosed approximations. But again, most of that uplift comes from Prodalim.
| Holding | What the company discloses as basis | Value shortly before publication | Accounting route | What that means |
|---|---|---|---|---|
| AKVA | About $74 million invested, $58 million carrying value at December 31, 2025 | About $73 million | Fair value through other comprehensive income | Visible value, but not a recurring earnings engine |
| NOAP | About $13.3 million cumulative investment, $18 million carrying value at December 31, 2025 | About $16 million | Fair value through other comprehensive income | Small operating option with a long way to go |
| Prodalim | About $116 million total investment | About $155 million | Equity method | The only holding that is beginning to resemble a second pillar, but still without matching earnings weight |
Prodalim Is the Only Holding That Has Clearly Moved From Concept to Price
Among the three, Prodalim is the only holding that now has a local market reference point, a clearer accounting bridge, and a near-term event that pushes the story forward. Israel Corp completed the investment and secondary share purchase in March 2025 for a total of about $116 million, in exchange for about 27.5% of Prodalim on a fully diluted basis. After the IPO in February 2026, the stake fell to about 23.26% on a fully diluted basis, and the value of the holding shortly before publication was already about $155 million.
That is the core of the story because it is difficult to dismiss this as mere option value. There is a market price, there is public price discovery, and there is evidence that the investment has already crossed an important credibility threshold. But the filing also puts a clear ceiling on the excitement. Israel Corp did not sell Prodalim shares in the offering, so the IPO improved value visibility, not holding-company liquidity. That matters a great deal in a holdco structure: a quoted price is not the same thing as cash reaching the parent layer.
The accounting effect disclosed in the filing also tells a more restrained story than the headline. The company expects to record a capital gain of about $11 million in the first quarter of 2026, based on Prodalim’s September 30, 2025 and December 31, 2025 financial statements. That is meaningful, but it is not the kind of number that suddenly redraws the economics of Israel Corp on its own.
And what about current earnings power? The filing is measured there as well. In the board report bridge, Prodalim contributed only about $2 million to net income attributable to Israel Corp shareholders in 2025. On a 100% basis, Prodalim’s profit included in the period was about $7 million from the acquisition date. That is exactly the gap between a value layer and a second engine: this is an asset that has already proved it can carry a price, but not yet an asset that carries enough attributable earnings weight.
So if the question is which holding could eventually become a second pillar, Prodalim is the obvious candidate. If the question is whether that has already happened, the filing still stops short of saying yes.
AKVA and NOAP Form a Real Strategic Cluster, but Not Yet a Second Anchor
AKVA and NOAP sit on one strategic thesis rather than two random minority investments. AKVA is an approximately 18% stake in a listed Norwegian aquaculture technology company. Under the investment terms, Israel Corp is entitled to appoint one AKVA director as long as it holds at least 12% of the share capital, and a joint advisory committee was also established around strategy, technology and innovation. This is already more than a passive portfolio position.
NOAP completes that thesis. Israel Corp holds about 9%, and NOAP operates a land-based salmon farming facility in China through a wholly owned local subsidiary, with AKVA acting as the primary technology equipment supplier. So at the strategic level this is a coherent cluster: a technology supplier on one side and an operating deployment platform on the other.
But this is also where the line runs between an interesting cluster and a mature second value layer. Economically, the two holdings together are worth less than $90 million shortly before publication. That is not immaterial, but it is also nowhere near enough to challenge Prodalim inside the non-ICL bucket, let alone create a true sense of balance against ICL.
The filing also shows that this layer remains volatile. At December 31, 2025, AKVA’s carrying value stood at about $58 million, and shortly before publication it had risen to about $73 million. NOAP moved the other way, from $18 million at year-end to $16 million shortly before publication. So even inside this smaller layer, AKVA provided most of the immediate mark-up, while NOAP still has not shown that its economic value is advancing at the pace implied by the strategic story.
That matters even more in NOAP because the operating build-out is still incomplete. The facility’s current production capacity stands at 4,000 tons, while the financing rounds were meant to support an expansion to 8,000 tons, and the second part of the facility has not yet been completed. So NOAP currently looks like a real operating option, but not yet like a stable value block.
The implication is that AKVA and NOAP do give Israel Corp a strategic platform outside ICL. The filing still does not justify the stronger claim that this platform has already matured into a second economic anchor.
What Still Has To Happen Before This Becomes a True Second Pillar
The first obstacle is concentration inside the diversification. If nearly two thirds of the layer sits in Prodalim, then the story is not really “three holdings built a new floor.” It is mostly “Prodalim, plus two smaller options.”
The second obstacle is the gap between visible value and accessible value. AKVA and NOAP sit in fair-value-through-OCI treatment, while Prodalim’s IPO created a public price without creating cash at Israel Corp because no shares were sold in the offering. So what the company has today is a better ability to measure value, not proof that the value is already available to Israel Corp shareholders at the parent level.
The third obstacle is the gap between strategic narrative and earnings weight. Prodalim added only $2 million to attributable profit in 2025, and AKVA and NOAP are not measured through a route that creates a comparable share-of-profit line. That does not cancel the value, but it does mean that the second layer currently lives more in balance-sheet and market-value terms than in the income statement.
Conclusion
There is already a real second value layer outside ICL, but not yet a real second engine. That is very different from saying these holdings are just paper options. Prodalim already has a market price, AKVA shows that upside can be marked and observed, and NOAP gives Israel Corp exposure to an operating thesis that has not matured yet. But as of this filing, the layer is still narrow, concentrated, and much more dependent on valuation evidence than on earnings or cash evidence.
If the question is when Israel Corp starts to look less like a holdco of ICL and more like a holdco with two legs, the process has clearly begun. If the question is whether the second leg is already carrying comparable weight, investors still need to wait. That will require Prodalim to translate IPO visibility into more meaningful accounting and operating contribution, and it will require the AKVA-NOAP cluster to move from an interesting strategic story to a larger and more stable value block.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.